Search results for paxillin

Human Paxillin (PXN) ELISA Kit, Abbexa, abx252902

Human Paxillin (PXN) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Paxillin concentrations in serum, plasma and other biological fluids.

Anti-PXN/Paxillin Antibody (R1B11), AntibodySystem, RHE62401

Chicken Paxillin (PXN) ELISA Kit, Abbexa, abx354653

Chicken Paxillin (PXN) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Chicken Paxillin concentrations in serum, plasma and other biological fluids.

Mouse Paxillin (PXN) ELISA Kit, Abbexa, abx352931

Mouse Paxillin (PXN) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Mouse Paxillin concentrations in tissue homogenates, cell lysates and other biological fluids.

PE Anti-Paxillin antibody [E228], Abcam, AB305907

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Paxillin antibody [Y113], Abcam, AB319473

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Rat Paxillin (PXN) ELISA Kit, Abbexa, abx518597

Rat Paxillin (PXN) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat Paxillin concentrations in tissue homogenates, cell lysates and other biological fluids.

Human Paxillin (PXN) ELISA Kit, Abbexa, abx350910

Human Paxillin (PXN) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Paxillin concentrations in tissue homogenates, cell lysates and other biological fluids.

APC Anti-Paxillin antibody [E228], Abcam, AB305908

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-Paxillin antibody [Y113], Abcam, AB319338

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.